Nuvectis Pharma, Inc. (NVCT)
NASDAQ: NVCT · Real-Time Price · USD
9.67
-0.79 (-7.55%)
Mar 31, 2025, 1:16 PM EDT - Market open
Nuvectis Pharma Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for Nuvectis Pharma stock have an average target of 15, with a low estimate of 11 and a high estimate of 19. The average target predicts an increase of 55.12% from the current stock price of 9.67.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Nuvectis Pharma stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 |
---|---|---|---|---|---|---|
Strong Buy | 1 | 1 | 1 | 1 | 1 | 2 |
Buy | 0 | 0 | 0 | 0 | 0 | 0 |
Hold | 0 | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 1 | 1 | 1 | 1 | 1 | 2 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Laidlaw & Co. | Laidlaw & Co. | Strong Buy Initiates $19 | Strong Buy | Initiates | $19 | +96.48% | Mar 17, 2025 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $21 → $11 | Strong Buy | Maintains | $21 → $11 | +13.75% | Feb 25, 2025 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $21 | Strong Buy | Reiterates | $21 | +117.17% | Aug 6, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $21 | Strong Buy | Reiterates | $21 | +117.17% | May 8, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $21 | Strong Buy | Reiterates | $21 | +117.17% | Sep 15, 2023 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-1.04
from -1.11
EPS Next Year
-1.11
from -1.04
Revenue Forecast
Revenue | 2025 | 2026 | 2027 |
---|---|---|---|
High | n/a | n/a | 65.4M |
Avg | n/a | n/a | 15.9M |
Low | n/a | n/a | n/a |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 |
---|---|---|---|
High | - | - | - |
Avg | - | - | - |
Low | - | - | - |
EPS Forecast
EPS | 2025 | 2026 | 2027 |
---|---|---|---|
High | -0.89 | -0.70 | 1.40 |
Avg | -1.04 | -1.11 | -0.61 |
Low | -1.22 | -1.60 | -1.83 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 |
---|---|---|---|
High | - | - | - |
Avg | - | - | - |
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.